{"DataElement":{"publicId":"3928558","version":"1","preferredName":"Non-Malignant Liver Disease or Disorder  Diagnosis Type","preferredDefinition":"Any non -neoplastic disease or dysfunction of the liver as a result of the investigation, analysis,and recognition of the presence and nature of such diseases as expressed as signs and symptoms or via  the concise results of such an investigation.","longName":"Non-_Live_Dise_Diag_Non-_Live_","context":"NRG","contextVersion":"1","DataElementConcept":{"publicId":"3928483","version":"1","preferredName":"Non-Neoplastic Liver and Intrahepatic Bile Duct Disorder","preferredDefinition":"Information related to any non -neoplastic disease or dysfunction of the liver as a result of the investigation, analysis,and recognition of the presence and nature of such diseases as expressed as signs and symptoms or via  the concise results of such an investigation._A non-neoplastic disorder that affects the liver parenchyma and the intrahepatic bile ducts. Representative examples include hepatitis, cirrhosis, and cholangitis.","longName":"Non-_Diag","context":"NRG","contextVersion":"1","ObjectClass":{"publicId":"3944352","version":"1","preferredName":"Non-Neoplastic Liver and Intrahepatic Bile Duct Disorder","preferredDefinition":"A non-neoplastic disorder that affects the liver parenchyma and the intrahepatic bile ducts. Representative examples include hepatitis, cirrhosis, and cholangitis.","longName":"C53550","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Non-Neoplastic Liver and Intrahepatic Bile Duct Disorder","conceptCode":"C53550","definition":"A non-neoplastic disorder that affects the liver parenchyma and the intrahepatic bile ducts. Representative examples include hepatitis, cirrhosis, and cholangitis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"EA246E24-7A1A-70C5-E040-BB89AD4361E3","latestVersionIndicator":"Yes","beginDate":"2013-11-01","endDate":null,"createdBy":"GRANTD","dateCreated":"2013-11-01","modifiedBy":"ONEDATA","dateModified":"2013-11-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2239981","version":"1","preferredName":"Diagnosis","preferredDefinition":"The process of identifying a disease by the signs and symptoms.","longName":"C15220","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diagnosis","conceptCode":"C15220","definition":"The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9FD4EEB-1C71-0B27-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-26","modifiedBy":"ONEDATA","dateModified":"2005-06-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"RTOG CRF:Radiation Therapy Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E96D68D1-95D9-3532-E040-BB89AD435FE7","latestVersionIndicator":"Yes","beginDate":"2013-10-23","endDate":null,"createdBy":"GRANTD","dateCreated":"2013-10-23","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Changed from CTEP to NRG for by script Fri Jan 24 11:30:54 EST 2014","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3928552","version":"1","preferredName":"Non-Malignant Liver Diagnosis Type","preferredDefinition":"Any non- neoplastic disease or dysfunction of the liver.","longName":"Non-_Live_Diag_Type","context":"NRG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"None","valueDescription":"None at all","ValueMeaning":{"publicId":"2574138","version":"1","preferredName":"None at all","longName":"2574138","preferredDefinition":"No person or thing, nobody, not any.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"None","conceptCode":"C41132","definition":"No person or thing, nobody, not any.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EEA7-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-14","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-14","modifiedBy":"CLOHNES","dateModified":"2022-08-12","changeDescription":null,"administrativeNotes":"8/12/22 added alt VM for Alliance cjl;","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E96E7DE5-B5F7-BB83-E040-BB89AD435461","beginDate":"2013-10-23","endDate":null,"createdBy":"GRANTD","dateCreated":"2013-10-23","modifiedBy":"ONEDATA","dateModified":"2013-10-23","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2991873","version":"1","preferredName":"Other","longName":"2991873","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7DC8B94A-9F2D-1457-E040-BB89AD430D33","latestVersionIndicator":"Yes","beginDate":"2010-01-22","endDate":null,"createdBy":"AHMEDS","dateCreated":"2010-01-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":"Concept annotation added for UPitt/TCGA.  WZhang, 02/23/2015","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E96E7DE5-B601-BB83-E040-BB89AD435461","beginDate":"2013-10-23","endDate":null,"createdBy":"GRANTD","dateCreated":"2013-10-23","modifiedBy":"ONEDATA","dateModified":"2013-10-23","deletedIndicator":"No"},{"value":"Hepatotoxic drug induced cirrhosis","valueDescription":"Hepatotoxic drug induced cirrhosis","ValueMeaning":{"publicId":"3928553","version":"1","preferredName":"Hepatotoxic drug induced cirrhosis","longName":"3928553","preferredDefinition":"Hepatotoxic drug induced cirrhosis","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E96E7DE5-B60B-BB83-E040-BB89AD435461","latestVersionIndicator":"Yes","beginDate":"2013-10-23","endDate":null,"createdBy":"GRANTD","dateCreated":"2013-10-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E96E7DE5-B624-BB83-E040-BB89AD435461","beginDate":"2013-10-23","endDate":null,"createdBy":"GRANTD","dateCreated":"2013-10-23","modifiedBy":"ONEDATA","dateModified":"2013-10-23","deletedIndicator":"No"},{"value":"Alpha 1-antitrypsin deficiency","valueDescription":"Alpha 1-antitrypsin deficiency","ValueMeaning":{"publicId":"3928554","version":"1","preferredName":"Alpha 1-antitrypsin deficiency","longName":"3928554","preferredDefinition":"Alpha 1-antitrypsin deficiency","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E96E7DE5-B62E-BB83-E040-BB89AD435461","latestVersionIndicator":"Yes","beginDate":"2013-10-23","endDate":null,"createdBy":"GRANTD","dateCreated":"2013-10-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E96E7DE5-B647-BB83-E040-BB89AD435461","beginDate":"2013-10-23","endDate":null,"createdBy":"GRANTD","dateCreated":"2013-10-23","modifiedBy":"ONEDATA","dateModified":"2013-10-23","deletedIndicator":"No"},{"value":"Wilson's Disease","valueDescription":"Wilson's Disease","ValueMeaning":{"publicId":"3928555","version":"1","preferredName":"Wilson's Disease","longName":"3928555","preferredDefinition":"Wilson's Disease","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E96E7DE5-B651-BB83-E040-BB89AD435461","latestVersionIndicator":"Yes","beginDate":"2013-10-23","endDate":null,"createdBy":"GRANTD","dateCreated":"2013-10-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E96E7DE5-B66A-BB83-E040-BB89AD435461","beginDate":"2013-10-23","endDate":null,"createdBy":"GRANTD","dateCreated":"2013-10-23","modifiedBy":"ONEDATA","dateModified":"2013-10-23","deletedIndicator":"No"},{"value":"Autoimmune hepatitis","valueDescription":"Autoimmune Hepatitis","ValueMeaning":{"publicId":"3210889","version":"1","preferredName":"Autoimmune Hepatitis","longName":"3210889","preferredDefinition":"Hepatitis caused by autoantibodies. Drugs, infections, and toxins may trigger the production of the autoantibodies against the liver parenchyma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Autoimmune Hepatitis","conceptCode":"C27029","definition":"Hepatitis caused by autoantibodies. Drugs, infections, and toxins may trigger the production of the autoantibodies against the liver parenchyma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-B01E-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E96E7DE5-B67E-BB83-E040-BB89AD435461","beginDate":"2013-10-23","endDate":null,"createdBy":"GRANTD","dateCreated":"2013-10-23","modifiedBy":"ONEDATA","dateModified":"2013-10-23","deletedIndicator":"No"},{"value":"Primary biliary cirrhosis","valueDescription":"Primary Biliary Cirrhosis","ValueMeaning":{"publicId":"3210799","version":"1","preferredName":"Primary Biliary Cirrhosis","longName":"3210799","preferredDefinition":"An autoimmune inflammatory disorder characterized by destruction of the small intrahepatic bile ducts. It affects predominantly females and it may lead to cirrhosis and liver failure. Patients have antimitochondrial and antinuclear antibodies in the peripheral blood.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Primary Biliary Cirrhosis","conceptCode":"C27167","definition":"An autoimmune inflammatory disorder characterized by destruction of the small intrahepatic bile ducts. It affects predominantly females and it may lead to cirrhosis and liver failure. Patients have antimitochondrial and antinuclear antibodies in the peripheral blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-A1AA-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E96E7DE5-B692-BB83-E040-BB89AD435461","beginDate":"2013-10-23","endDate":null,"createdBy":"GRANTD","dateCreated":"2013-10-23","modifiedBy":"ONEDATA","dateModified":"2013-10-23","deletedIndicator":"No"},{"value":"Hereditary hemochromatosis","valueDescription":"Hereditary hemochromatosis","ValueMeaning":{"publicId":"3928556","version":"1","preferredName":"Hereditary hemochromatosis","longName":"3928556","preferredDefinition":"Hereditary hemochromatosis","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E96E7DE5-B69C-BB83-E040-BB89AD435461","latestVersionIndicator":"Yes","beginDate":"2013-10-23","endDate":null,"createdBy":"GRANTD","dateCreated":"2013-10-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E96E7DE5-B6B5-BB83-E040-BB89AD435461","beginDate":"2013-10-23","endDate":null,"createdBy":"GRANTD","dateCreated":"2013-10-23","modifiedBy":"ONEDATA","dateModified":"2013-10-23","deletedIndicator":"No"},{"value":"Hepatitis B","valueDescription":"Hepatitis B","ValueMeaning":{"publicId":"2946400","version":"1","preferredName":"Hepatitis B","longName":"2946400","preferredDefinition":"A viral hepatitis caused by the Hepatitis B virus.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hepatitis B Infection","conceptCode":"C3097","definition":"A viral infection caused by the hepatitis B virus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7472988E-D1A5-00A0-E040-BB89AD433FCF","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-09-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E96E7DE5-B6BF-BB83-E040-BB89AD435461","beginDate":"2013-10-23","endDate":null,"createdBy":"GRANTD","dateCreated":"2013-10-23","modifiedBy":"ONEDATA","dateModified":"2013-10-23","deletedIndicator":"No"},{"value":"Hepatitis C","valueDescription":"Hepatitis C","ValueMeaning":{"publicId":"2567488","version":"1","preferredName":"Hepatitis C","longName":"2567488","preferredDefinition":"viral disease caused by hepatitis C virus; most common form of post transfusion hepatitis, also is a common acute sporadic hepatitis; may also follow parental drug abuse.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hepatitis C Infection","conceptCode":"C3098","definition":"A viral infection caused by the hepatitis C virus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D4AD-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-12-19","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E96E7DE5-B6CA-BB83-E040-BB89AD435461","beginDate":"2013-10-23","endDate":null,"createdBy":"GRANTD","dateCreated":"2013-10-23","modifiedBy":"ONEDATA","dateModified":"2013-10-23","deletedIndicator":"No"},{"value":"Non- alcoholic steatohepatitis(NASH)","valueDescription":"Non-alcoholic steatohepatitis","ValueMeaning":{"publicId":"3928557","version":"1","preferredName":"Non-alcoholic steatohepatitis","longName":"3928557","preferredDefinition":"Non-alcoholic steatohepatitis","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E96E7DE5-B6D5-BB83-E040-BB89AD435461","latestVersionIndicator":"Yes","beginDate":"2013-10-23","endDate":null,"createdBy":"GRANTD","dateCreated":"2013-10-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E96E7DE5-B6EE-BB83-E040-BB89AD435461","beginDate":"2013-10-23","endDate":null,"createdBy":"GRANTD","dateCreated":"2013-10-23","modifiedBy":"ONEDATA","dateModified":"2013-10-23","deletedIndicator":"No"},{"value":"Alcoholic liver disease","valueDescription":"Alcoholic Liver Disease","ValueMeaning":{"publicId":"3210771","version":"1","preferredName":"Alcoholic Liver Disease","longName":"3210771","preferredDefinition":"A disorder caused by damage to the liver parenchyma due to alcohol consumption. It may present with an acute onset or follow a chronic course, leading to cirrhosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Alcoholic Liver Disease","conceptCode":"C34783","definition":"A disorder caused by damage to the liver parenchyma due to alcohol consumption. It may present with an acute onset or follow a chronic course, leading to cirrhosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-9D1A-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E96E7DE5-B702-BB83-E040-BB89AD435461","beginDate":"2013-10-23","endDate":null,"createdBy":"GRANTD","dateCreated":"2013-10-23","modifiedBy":"ONEDATA","dateModified":"2013-10-23","deletedIndicator":"No"},{"value":"Primary Sclerosing Cholangitis","valueDescription":"Primary Sclerosing Cholangitis","ValueMeaning":{"publicId":"3210800","version":"1","preferredName":"Primary Sclerosing Cholangitis","longName":"3210800","preferredDefinition":"A chronic, autoimmune inflammatory liver disorder characterized by narrowing and scarring of the lumen of the bile ducts. It is often seen in patients with ulcerative colitis. Signs and symptoms include jaundice, fatigue, and malabsorption. It may lead to cirrhosis and liver failure.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Primary Sclerosing Cholangitis","conceptCode":"C4828","definition":"A chronic, autoimmune inflammatory liver disorder characterized by narrowing and scarring of the lumen of the bile ducts. It is often seen in patients with ulcerative colitis. Signs and symptoms include jaundice, fatigue, and malabsorption. It may lead to cirrhosis and liver failure.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-A1CC-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6273AAFA-4607-4DB7-E053-F662850ABEAC","beginDate":"2018-01-10","endDate":null,"createdBy":"PATELV","dateCreated":"2018-01-10","modifiedBy":"ONEDATA","dateModified":"2018-01-10","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3928551","version":"1","preferredName":"Non-Malignant Liver Diagnosis Type","preferredDefinition":"Not cancerous.:A triangular-shaped organ located under the diaphragm in the right hypochondrium. It is the largest internal organ of the body, weighting up to 2 kg. Metabolism and bile secretion are its main functions. It is composed of cells which have the ability to regenerate.:The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.:Something distinguishable as an identifiable class based on common qualities.","longName":"C25588:C12392:C15220:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Non-Malignant","conceptCode":"C25588","definition":"For neoplasms, a neoplastic process that, at the time of the pathologic diagnosis, does not show evidence of tissue infiltration and may or may not show evidence of atypical morphologic features (e.g., cellular atypia, formation of complex structures, cellular pseudostratification, and increased mitotic activity).  This term encompasses benign neoplastic processes, neoplastic processes with dysplastic features, and borderline processes.  The former do not metastasize and the latter two are associated with a future risk of stromal invasion and metastasis. For other conditions, a process that is not seriously resistant to treatment or dangerous to health.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Liver","conceptCode":"C12392","definition":"A triangular-shaped organ located under the diaphragm in the right hypochondrium. It is the largest internal organ of the body, weighting up to 2 kg. Metabolism and bile secretion are its main functions. It is composed of cells which have the ability to regenerate.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Diagnosis","conceptCode":"C15220","definition":"The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E96E7DE5-B5D3-BB83-E040-BB89AD435461","latestVersionIndicator":"Yes","beginDate":"2013-10-23","endDate":null,"createdBy":"GRANTD","dateCreated":"2013-10-23","modifiedBy":"ONEDATA","dateModified":"2013-10-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E96E7DE5-B5E4-BB83-E040-BB89AD435461","latestVersionIndicator":"Yes","beginDate":"2013-10-23","endDate":null,"createdBy":"GRANTD","dateCreated":"2013-10-23","modifiedBy":"PATELV","dateModified":"2018-01-10","changeDescription":"Changed from CTEP to NRG for by script Fri Jan 24 11:30:54 EST 2014","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3896529","version":"1","longName":"Consortia 2012 Studies","context":"DCP","ClassificationSchemeItems":[{"publicId":"5889179","version":"1","longName":"NWU2016-08-02","context":"DCP"}]},{"publicId":"4057943","version":"1","longName":"Disease Site","context":"NRG","ClassificationSchemeItems":[{"publicId":"4104993","version":"1","longName":"RTOG-1112","context":"NRG"}]}],"AlternateNames":[{"name":"Non-_Live_Dise_Diag_Non-_Live_","type":"USED_BY","context":"NRG"},{"name":"DCP","type":"USED_BY","context":"DCP"}],"ReferenceDocuments":[{"name":"Non- malignant liver disease","type":"Preferred Question Text","description":"Non- malignant liver disease type?","url":null,"context":"NRG"},{"name":"DCP-Text-1","type":"Alternate Question Text","description":"Liver Disease","url":null,"context":"DCP"}],"origin":"REAL Classification","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E96E7DE5-B832-BB83-E040-BB89AD435461","latestVersionIndicator":"Yes","beginDate":"2013-10-23","endDate":null,"createdBy":"GRANTD","dateCreated":"2013-10-23","modifiedBy":"TITARENKOI","dateModified":"2020-04-28","changeDescription":"Changed from CTEP to NRG for by script Fri Jan 24 11:30:54 EST 2014","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}